Home LiteratureArticle Details
PMID: 10329802 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

The role of Fas and related death receptors in autoimmune and other disease states.

The Journal of allergy and clinical immunology ·Vol. 103 ·No. 5 Pt 1 ·1999-05-00 ·Pages 729-38

Siegel RM, Fleisher TA

Abstract

The Fas receptor, also known as APO-1 or CD95, has emerged as a key initiator of apoptotic programmed cell death in a variety of cell types. CD4(+) T cells are unique in their ability to commit "suicide" by stimulating their own Fas receptors with secreted or membrane-bound Fas ligand. This takes place in the setting of repeated stimulation with T-cell antigens and is thought to be a mechanism for controlling the expansion of T cells during viral infections and autoimmune disease states. T cells can also trigger apoptosis in B cells, macrophages, and other cell types through Fas ligand. These interactions negatively regulate the immune system but can also contribute to immunopathology, as occurs in Fas-mediated damage of target tissues in hepatitis and other organ-specific autoimmune diseases. The dual role of Fas in the immune response complicates the understanding of its role in disease states and may limit its potential as a therapeutic target. Despite the many roles of Fas in immunoregulation, findings in experimental mouse strains and human patients with genetic deficiencies in the Fas pathway have shown that the main result of disrupting this pathway in vivo is systemic autoimmunity and a predisposition toward lymphoid malignancies. The role of Fas in various cell types and the lessons we have learned from Fas-deficient patients with the autoimmune lymphoproliferative syndrome will be discussed.

MeSH Terms
Animals Autoimmune Diseases/immunology Humans Receptors, Tumor Necrosis Factor/physiology fas Receptor
Chemicals
Receptors, Tumor Necrosis Factor fas Receptor
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Siegel R M
Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, and the Clinical Pathology Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
Fleisher T A
Article Info
Journal
The Journal of allergy and clinical immunology
Abbr.
J Allergy Clin Immunol
ISSN
0091-6749
Published
1999-05-00
Pages
729-38
Language
English
Region
United States
NLM ID
1275002
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com